- Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29: 19–24.
- Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial aetiology of nosocomial infections. Am J Med 1991; 91 Suppl 3B: S72–5.
- Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High level resistance to Gentamicin in Steptococcus faecalis: Risk factors and evidence for exogenous acquisition of infection. J Infect Dis 1986; 153: 1075–83.
- Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; i: 57–8.
- Morris JG, Jr, Shay DK, Hebden JN, McCarter RJ, Jr, Perdue BE, Jarvis W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med 1995; 123: 250–9.
- Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin – United States, 1989–1993. MMWR 1993; 42: 597–9.
- Mainous MR, Lipsett PA, O’Brien M. Enterococcal bacteremia in the surgical intensive care unit. Arch Surg 1997; 132: 76–81.
- Rimalho A, Lampl E, Riou B, Richard C, Rottman E, Auzery P. Enteroccocal bacteremia in a medical intensive care unit. Crit Care Med 1988; 16: 126–9.
- Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, Stobbering EE. Colonization and infection with Enterococcus faecalis in intensive care units: the role of antimicrobial agents. Antimicrob Agents Chemother 1995; 39: 2783–6.
- Spencer RC. Epidemiology of infection in ICUs. Intensive Care Med 1994; 20: S2–6.
- Wiederman B. Challengens of bacterial infections in European ICUs: Clinical Intensive Care 1996; 7 Suppl 6: 14–8.
- Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in Intensive Care Units in Europe. JAMA 1995; 274: 639–44.
- Vandamme P, Vercauteren E, Lammens C, Pensart N, Ieven M, Pot, et al. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 1996; 34: 2572–6.
- Bell JM, Paton JC, Turnidge J. Emergence of vancomycin resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998; 36: 2187–90.
- Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med 1996; 154: 617–24.
- Allerberger F, Lass-Floerl C, Dierich MP, Hirschl AM, Presterl E, Haas G, et al. Vancomycin resistant entrrococci in Austria. Wiener Klinische Wochenschrift 1997; 109: 312–20.
- Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–40.
- Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–29.
- Le Gall JR, Lemeshow S, Saulnier F. A New Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957–63.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA, 1993.
- Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis Bacteremia: Acquisition and outcome. Clin Infect Dis 1995; 20: 296–301.
- Burnett RJ, Haverstock DC, Dellinger P, Reinhart HH, Bohnen JM, Rotstein OD, et al. Definition of the role of enterococcus in intrabdominal infection: Analysis of a prospective randomized trial. Surgery 1995; 118: 716–21.
- Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126–33.
- Boyle JR, Soumakis SA, Rendo A, Herrington JA, Gianarkis DG, Thurberg BE, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 1280–5.
- Suppola JP, Kuikka A, Vaara M, Valtonen V. Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteremia. Scand J Infect Dis 1998; 30: 153–7.
- Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, et al. Epidemiology and mortality risk of vancomycin-resistant Enterococcal bloodstream infections. J Infect Dis 1995; 172: 993–1000.
- McCarthy AE, Victor G, Ramotar K, Toye B. Risk factors for acquiring ampicillin-resistant Enterococci and clinical outcomes at a Canadian tertiary hospital. J Clin Microbiol 1994; 32: 2671–6.
- Moellering RC, Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992; 14: 1173–8.
- Liassine N, Frei R, Jan I, Auckenthaler R. Characterization of glycopeptide-resistant Enterococci from a Swiss hospital. J Clin Microbiol 1998; 36: 1853–8.
Enterococcal Infections in a Greek Intensive Care Unit: A 5-y Study
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.